Some questions never seem to stop coming up. Should every single incidental finding be reported? If so, how so? In what sorts of cases might the reporting mislead clinicians rather than appropriately guide patient care? Here’s a fresh look at these perpetual concerns.
The rate of cancer incidence and deaths among African Americans has surpassed that of whites for decades, but recent data from the American Cancer Society suggests that the “cancer gap” is shrinking, according to a recent report from NPR.
Following radiation therapy for liver metastases, patients are just as well monitored with contrast-enhanced ultrasound as with contrast-enhanced CT, according to the authors of a pilot study running in the March edition of the Journal of Ultrasound in Medicine.
Exposure to dichlorodiphenyltrichloroethane (DDT) puts women at an increased risk of breast cancer through the age of 54, according to research published by the Journal of the National Cancer Institute.
A new imaging technique for carotid artery assessment can reveal key information about a patient’s risk of cardiovascular disease, according to a new study published in Radiology. Could it go on to be as popular as ultrasound?
PET imaging with 18F-fluorofuranylnorprogesterone (18F-FFNP) could help specialists treat patients with estrogen-receptor (ER)-positive breast cancer, according to a new study published in The Journal of Nuclear Medicine.